PRESS RELEASE published on 07/22/2025 at 08:30, 1 year 2 months ago Oxurion plans to launch a treasury diversification strategy into digital assets under a EUR 10M indicative agreement with its main investor Oxurion enters negotiations with Atlas Special Opportunities for a new €10 million convertible bond program to invest in Bitcoin and Ethereum, supporting long-term growth strategy Bitcoin Ethereum Atlas Special Opportunities Oxurion Convertible Bond Program
BRIEF published on 07/17/2025 at 09:05, 1 year 2 months ago Oxurion completes partial acquisition of Axiodis CRO Acquisition Funding Clinical Data Oxurion Axiodis CRO
PRESS RELEASE published on 07/17/2025 at 09:05, 1 year 2 months ago Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025 Oxurion NV secures financing for acquisition of Axiodis CRO, advancing strategic roadmap in clinical data. Targets identified for leading European hub Acquisition Financing Clinical Data Oxurion NV Axiodis CRO
BRIEF published on 07/17/2025 at 08:35, 1 year 2 months ago Oxurion Secures Financing for Major Acquisition Acquisition Biopharmaceutical Clinical Data Oxurion Europe Hub
PRESS RELEASE published on 07/17/2025 at 08:30, 1 year 2 months ago Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025 Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025 Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
BRIEF published on 07/15/2025 at 18:05, 1 year 2 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Shares Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE published on 07/15/2025 at 18:00, 1 year 2 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
BRIEF published on 07/14/2025 at 18:05, 1 year 2 months ago Oxurion Announces Transparency Notifications from Atlas Biopharmaceutical Shareholder Notification Atlas Special Opportunities Oxurion NV Transparency Legislation
PRESS RELEASE published on 07/14/2025 at 18:00, 1 year 2 months ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
BRIEF published on 07/10/2025 at 17:50, 1 year 2 months ago Oxurion Clears Regulatory Hurdle in Axiodis Acquisition Acquisition Regulatory Approval Oxurion Axiodis FDI Procedure
Published on 10/03/2026 at 02:35, 23 hours 21 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 12 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 12 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 12 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 10 hours 11 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 2 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 5 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 6 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 7 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 8 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 6 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 7 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 7 hours ago Covivio - Information on total number of voting rights and share capital